Dominique Turck,Torsten Bohn,Jacqueline Castenmiller,Stefaan De Henauw,Karen Ildico Hirsch‐Ernst,Alexandre Maciuk,Inge Mangelsdorf,Harry J. McArdle,Androniki Naska,Carmen Pelaez,Kristina Pentieva,Alfonso Siani,Frank Thies,Sophia Tsabouri,Marco Vinceti,Francesco Cubadda,Thomas Frenzel,Marina Heinonen,Miguel Prieto Maradona,Rosangela Marchelli,Monika Neuhäuser‐Berthold,Morten Poulsen,Josef Rudolf Schlatter,Reinhard Ackerl,Helle Katrine Knutsen,,Henk van Loveren

Abstract:Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of an extension of use for Yarrowia lipolytica yeast biomass as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The extension of use pertains to the use of the NF as a food ingredient in single meal replacement products for weight reduction for adults at a maximum amount of 6 g NF per day, which is the same amount of NF as already authorised in food supplements for this population group. According to the applicant, food supplements with Yarrowia lipolytica biomass (as already authorised) should not be consumed concomitantly with the meal replacement products in order not to exceed the 6 g NF per day. The Panel considers that the consumption of the NF is not nutritionally disadvantageous under the proposed conditions of use. The Panel concludes that the NF, Yarrowia lipolytica yeast biomass, is safe under the proposed conditions of use.

Safety of an extension of use of Yarrowia lipolytica yeast biomass as a novel food pursuant to Regulation (EU) 2015/2283